3 Biotech Stocks for Enterprising Investors
The biotech sector isn't for the faint of heart. While investors can strike it rich if they get lucky, they can also lose a bundle if things don't go according to plan. Given the risk, it can take a lot of courage to put money to work in the sector.
Which biotech stocks do we think are smart picks for investors who are willing to accept some risk? We asked that question to a team of healthcare investors and they picked Edge Therapeutics (NASDAQ: EDGE), Aratana Therapeutics (NASDAQ: PETX) and Alkermes (NASDAQ: ALKS).
Image source: Getty Images.
Source: Fool.com
Eli Lilly Corp. Aktie
815,00 €
-0,73 %
Die Community ist sich einig: Eli Lilly Corp. nur mit Buy-Einschätzungen, keine Sell-Einschätzungen.
Ein Kursziel von 831 € für Eli Lilly Corp. zeigt ein leicht positives Potenzial im Vergleich zum aktuellen Kurs von 815.0 €.
